Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell death in acromegalic cardiomyopathy.

A Frustaci1, C Chimenti, M Setoguchi

  • 1Departments of Cardiology and Endocrinology, Sacred Heart Catholic University, Rome, Italy.

Circulation
|March 23, 1999
PubMed
Summary

Prolonged acromegaly causes significant heart muscle cell death (apoptosis), contributing to ventricular dysfunction and heart failure. This cell death correlates with disease severity and impaired heart function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multitarget drugs of plants origin acting on Alzheimer's disease.

Current medicinal chemistry·2013
Same author

From traditional European medicine to discovery of new drug candidates for the treatment of dementia and Alzheimer's disease: acetylcholinesterase inhibitors.

Current medicinal chemistry·2012
Same author

Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy.

Herz·2012
Same author

Rehabilitation of traumatic brain injury in Italy: a multi-centred study.

Brain injury·2011
Same author

Resident cardiac stem cells.

Current pharmaceutical design·2011
Same author

Role of stem cells in cardiovascular biology.

Journal of thrombosis and haemostasis : JTH·2011

Area of Science:

  • Cardiology
  • Endocrinology
  • Cell Biology

Background:

  • Prolonged acromegaly results in myopathy and cardiac dysfunction.
  • The precise mechanisms behind cardiac pump function alterations in acromegaly are not fully understood.
  • Myocyte apoptosis is a potential contributor to ventricular dysfunction in acromegaly.

Purpose of the Study:

  • To investigate the presence and extent of myocyte and nonmyocyte apoptosis in the hearts of patients with acromegaly.
  • To determine the correlation between apoptosis, cardiac dysfunction, and disease characteristics in acromegaly.

Main Methods:

  • Quantitative analysis of endomyocardial biopsies from acromegalic patients and controls.
  • Assessment of myocyte and nonmyocyte apoptosis using confocal microscopy and histochemical methods (TdT assay, Taq probe in situ ligation).

Related Experiment Videos

  • Evaluation of cardiac function through electrocardiography, Holter monitoring, echocardiography, and cardiac catheterization.

    • Main Results:

    • Acromegaly showed a significant increase in myocyte (495-fold) and nonmyocyte (305-fold) apoptosis.
    • Myocyte apoptosis magnitude correlated with reduced ejection fraction and longer disease duration.
    • Collagen accumulation, indicating prior myocyte necrosis, also correlated with myocyte apoptosis.

    Conclusions:

    • Myocyte cell death, both apoptotic and necrotic, plays a critical role in the development and progression of ventricular dysfunction in acromegaly.
    • These findings highlight the importance of understanding cell death pathways in acromegaly-related heart disease.
    • Targeting myocyte apoptosis could be a potential therapeutic strategy for acromegaly-induced cardiomyopathy.